title: Words of Wisdom. Re: Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony).
authors.affiliation: Hospital of S João, Faculty of Medicine of Porto and Instituto de Biologia Molecular e Celular, Porto, Portugal. Electronic address: cruzf@jmred.up.pt.
authors.forename: Francisco
authors.initials: F
authors.lastname: Cruz
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D000069464:Solifenacin Succinate / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D001743:Urinary Bladder / Q000187:drug effects*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D000083:Acetanilides; D058667:Adrenergic beta-3 Receptor Agonists; D018727:Muscarinic Antagonists; D013844:Thiazoles; D064804:Urological Agents; D000069464:Solifenacin Succinate